Male infertility may be caused by genetic defects that increase in prevalence when spermatogenesis is severely impaired. Thus, especially infertile men with severe oligozoospermia or azoospermia should be investigated by cytogenetic and molecular genetic analysis. Structural chromosomal aberrations (e.g., balanced translocations) are found significantly more frequently in oligo- and azoospermic men and numerical chromosomal aberrations of the sex chromosomes, especially Klinefelter syndrome (karyotype 47,XXY), are common among azoospermic men. Screening for Y-chromosomal AZF (“AZoospermia Factor”) deletions is warranted in all men with severe oligo- or azoospermia. Infertile men with obstructive azoospermia should be evaluated for mutations in the Cystic Fibrosis Transmembrane conductance Regulator (CFTR) gene. Detecting chromosomal aberrations, AZF deletions, and CFTR mutations has important prognostic value for the subsequent work-up and especially for genetic counseling about risk for offspring. Patients with Congenital Hypogonadotropic Hypogonadism (CHH), other syndromic forms of male infertility, or infertile men with rare monomorphic defects of spermatozoa should be carefully investigated for the underlying genetic cause. In the near future, men with severe spermatogenic failure may be evaluated by targeted sequencing of a panel of genes.
CITATION STYLE
Tüttelmann, F., & Röpke, A. (2017). Genetics of Male Infertility. In Endocrinology (Switzerland) (pp. 1–21). Springer Science and Business Media Deutschland GmbH. https://doi.org/10.1007/978-3-319-29456-8_34-1
Mendeley helps you to discover research relevant for your work.